US FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) – the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives
March 20, 2024 02:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult...
Preventing Disease and Optimizing Health: Dr. Mark Zhuk's Mission To Revolutionize Western Medicine with The Q Institute
March 19, 2024 09:40 ET
|
The Q Institute
Miami, Florida, March 19, 2024 (GLOBE NEWSWIRE) -- Medicine has become an indispensable sector of the modern world. However, there are many ways healthcare can become more efficient and effective...
Flavored Water Market Size is projected to reach USD 37.65 billion by 2031, growing at a CAGR of 10%: Straits Research
March 14, 2024 10:00 ET
|
Straits Research Private Limited
New York, United States, March 14, 2024 (GLOBE NEWSWIRE) -- Flavored water is a beverage in which natural or artificial flavors are infused into water, providing consumers with a refreshing and...
Fetal Monitoring Market revenue to reach USD 15.81 Billion by 2035, says Research Nester
March 13, 2024 06:00 ET
|
Research Nester
New York , March 13, 2024 (GLOBE NEWSWIRE) -- The global fetal monitoring market size is slated to expand at 10.20% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 15.81...
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
March 12, 2024 09:00 ET
|
HeartFlow Holding, Inc.
HeartFlow's non-invasive AI driven FFRCT predicts patient outcomes as effectively as the gold-standard invasive FFR out to 10 years MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) --...
Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease
March 08, 2024 13:42 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy® based on a supplemental New Drug Application...
Healthcare Digital Twin Market Size to Worth USD 38.43 Bn by 2032
March 08, 2024 11:25 ET
|
Precedence Research
Ottawa, March 08, 2024 (GLOBE NEWSWIRE) -- The global healthcare digital twin market size accounted for USD 2.24 billion in 2024, grew to USD 3.13 billion in 2025, and is expanding at a remarkable...
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
February 29, 2024 09:00 ET
|
Tenax Therapeutics
Dr. Sanjiv Shah, a renowned, global expert in the treatment of HFpEF and PH-HFpEF, will present data highlighting the use of levosimendan for the treatment of pulmonary hypertension due to heart...
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
February 29, 2024 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is joining the European Organisation for Rare Diseases (EURORDIS) and...
Euroseas Ltd. Announces Two-Year Time Charter Contract for its Fuel Efficient 2,800 teu Feeder Containership Newbuilding, M/V Leonidas Z, Commencing upon its Delivery
February 28, 2024 16:05 ET
|
Euroseas
ATHENS, Greece, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne...